{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:00:35Z","timestamp":1781812835690,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbadis.2023.166643","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:21:14Z","timestamp":1674037274000},"page":"166643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C\/EBP\u03b2"],"prefix":"10.1016","volume":"1869","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166643_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138920007779315008","article-title":"Hyperhomocysteinaemia: a critical review of old and new aspects","volume":"8","author":"Herrmann","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbadis.2023.166643_bb0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00467-006-0068-8","article-title":"Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension","volume":"21","author":"Litwin","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12325-019-01154-7","article-title":"The relationship between homocysteine, blood pressure variability, and left ventricular hypertrophy in patients with essential hypertension: an observational study","volume":"37","author":"Lin","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bbadis.2023.166643_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/nu8100645","article-title":"High prevalence of hyperhomocysteinemia and its association with target organ damage in chinese patients with chronic kidney disease","volume":"8","author":"Ye","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2023.166643_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12872-020-01350-2","article-title":"Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural chinese","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.bbadis.2023.166643_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FJC.0b013e3181de308b","article-title":"Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy","volume":"56","author":"Pal","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2019.00598","article-title":"Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction","volume":"10","author":"Kar","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00109-015-1281-3","article-title":"Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress","volume":"93","author":"Muthuramu","year":"2015","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbadis.2023.166643_bb0045","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.5551\/jat.34082","article-title":"Intermedin1-53 protects against myocardial fibrosis by inhibiting endoplasmic reticulum stress and inflammation induced by homocysteine in apolipoprotein e-deficient mice","volume":"23","author":"Zhang","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbadis.2023.166643_bb0050","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1139\/cjpp-2016-0744","article-title":"Ablation of toll-like receptor 4 mitigates cardiac mitochondrial dysfunction in hyperhomocysteinemia","volume":"95","author":"Jeremic","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-015-2383-5","article-title":"Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing mir-133a in cardiomyocytes","volume":"404","author":"Kesherwani","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2023.166643_bb0060","first-page":"12829","article-title":"Homocysteine induces cardiac hypertrophy by up-regulating atp7a expression","volume":"8","author":"Cao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0065","first-page":"388","article-title":"Endoplasmic reticulum stress mediates homocysteine-induced hypertrophy of cardiac cells through activation of cyclic nucleotide phosphodiesterase 1C","volume":"54","author":"Sun","year":"2022","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.bbadis.2023.166643_bb0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: a potential target for metabolic diseases","volume":"8","author":"He","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.bbadis.2023.166643_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0080","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jphp.13113","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol\/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition","volume":"71","author":"Zhang","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0085","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/CCM.0000000000000226","article-title":"Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2","volume":"42","author":"Zhang","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2023.166643_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1042\/BST0340228","article-title":"Remodelling Ca2+ signalling systems and cardiac hypertrophy","volume":"34","author":"Berridge","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2023.166643_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1570161111311040013","article-title":"Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy","volume":"11","author":"Gomez","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphys.2019.00159","article-title":"TRP channels: current perspectives in the adverse cardiac remodeling","volume":"10","author":"Falc\u00f3n","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0105","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1096\/fj.05-5560com","article-title":"Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart","volume":"20","author":"Nakayama","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2023.166643_bb0110","doi-asserted-by":"crossref","first-page":"33487","DOI":"10.1074\/jbc.M605536200","article-title":"Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling","volume":"281","author":"Bush","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166643_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11010-016-2784-0","article-title":"Resistance to pathologic cardiac hypertrophy and reduced expression of cav1.2 in trpc3-depleted mice","volume":"421","author":"Han","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2023.166643_bb0120","first-page":"1260","article-title":"Nicotine induces cardiomyocyte hypertrophy through trpc3-mediated Ca(2+)\/NFAT signalling pathway","volume":"32","author":"Li","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0125","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/ATVBAHA.107.152074","article-title":"Epoxyeicosatrienoic acids regulate TRP channel dependent Ca2+ signaling and hyperpolarization in endothelial cells","volume":"27","author":"Fleming","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/hr.2011.5","article-title":"Stable eet urea agonist and soluble epoxide hydrolase inhibitor regulate rat pulmonary arteries through TRPCs","volume":"34","author":"Liu","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbadis.2023.166643_bb0135","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","article-title":"C\/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling","volume":"143","author":"Bostrom","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2023.166643_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2014.03.007","article-title":"C\/EBPbeta knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFkappaB","volume":"390","author":"Zou","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2017.03.057","article-title":"Atorvastatin prevents angiotensin II induced myocardial hypertrophy in vitro via CCAAT\/enhancer-binding protein beta","volume":"486","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2023.166643_bb0150","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbamcr.2014.03.006","article-title":"Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins","volume":"1843","author":"Ghavami","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2023.166643_bb0155","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1038\/s41598-017-06247-3","article-title":"Impairment of coronary endothelial function by hypoxia-reoxygenation involves TRPC3 inhibition-mediated KCa channel dysfunction: implication in ischemia-reperfusion injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166643_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vph.2018.10.009","article-title":"Protection of dilator function of coronary arteries from homocysteine by tetramethylpyrazine: role of ER stress in modulation of BKCa channels","volume":"113","author":"Sun","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/FJC.0b013e3181ed088d","article-title":"Cytochrome p450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential c6 channels","volume":"57","author":"Loot","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature01807","article-title":"Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels","volume":"424","author":"Watanabe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166643_bb0175","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1038\/s41598-017-11274-1","article-title":"Structural determinants of 5',6'-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel","volume":"7","author":"Berna-Erro","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166643_bb0180","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2023.166643_bb0185","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/abbs\/gmw025","article-title":"The role of autophagy in cardiac hypertrophy","volume":"48","author":"Li","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:12:14Z","timestamp":1760418734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0925443923000078"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166643","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C\/EBP\u03b2","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166643"}}